DavidBWilsonMD

Pediatric Hematology & Oncology • Saint Louis, MO

Professor, Pediatrics, Washington University School of Medicine

Join to view full profile

Dr. Wilson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Wilson's full profile

Already have an account?

Office
1 Childrens Pl
# Div
Saint Louis, MO 63110
Phone+1 314-454-6018

Fax+1 844-621-4392

Education & Training

Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 1988 - 1989
Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 1986 - 1988
Washington University in St. Louis School of MedicineClass of 1986

Certifications & Licensure

IL State Medical License 2015 - 2026
MO State Medical License 1993 - 2025
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

Elected Member The American Society for Clinical Investigation, 1998

Clinical Trials

Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma Start of enrollment: 2001 Oct 18
Active, not recruiting
Phase 3
Study of Kidney Tumors in Younger Patients Start of enrollment: 2006 Feb 27
Recruiting
Collecting and Storing Biological Samples From Patients With Ewing Sarcoma Start of enrollment: 2008 Feb 04
Completed
Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma Start of enrollment: 2000 Nov 06
Recruiting
Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer Start of enrollment: 2009 Sep 14
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

11 citations
SLC-0111, an inhibitor of carbonic anhydrase IX, attenuates hepatoblastoma cell viability and migration.
Katja Eloranta, Marjut Pihlajoki, Emmi Liljeström, Ruth Nousiainen, Tea Soini
Frontiers in Oncology. 2023-01-01
9 citations
Type I and Ir pleuropulmonary blastoma (PPB): A report from the International PPB/DICER1 Registry.
Alexander T Nelson, Anne K Harris, Dave Watson, Doug Miniati, Mike Finch
Cancer. 2023-02-15
9 citations
Outcomes for Children With Type II and Type III Pleuropulmonary Blastoma Following Chemotherapy: A Report From the International PPB/Registry.
Kris Ann P Schultz, Anne K Harris, Alexander T Nelson, Dave Watson, John T Lucas Jr
Journal of Clinical Oncology. 2023-02-01